PGR and ovarian cancer: In contrast with breast cancer and prostate cancer, wherein the therapeutic and prognostic roles of AR, ER, and PR are already well established, the prognostic and predictive values of hormone receptors in ovarian cancer are inconsistent and sometimes contradictory [6,12].